Litcius/Paper detail

Preparation and anti-cancer activity of transferrin/folic acid double-targeted graphene oxide drug delivery system

Taicheng Lu, Zhenzhen Nong, Liying Wei, Mei Wei, Li Guo, WU Ni-ni, Cheng Liu, Bingling Tang, Qixiao Qin, Xuehua Li, Fa‐Yan Meng

2020Journal of Biomaterials Applications46 citationsDOI

Abstract

In this study, a transferrin/folic acid double-targeting graphene oxide drug delivery system loaded with doxorubicin was designed. Graphene oxide was prepared by ultrasound improved Hummers method and was modified with Pluronic F68, folic acid, and transferrin to decrease its toxicity and to allow dual-targeting. The results show that the double target drug delivery system (TFGP*DOX) has good and controllable drug delivery performance with no toxicity. Moreover, TFGP*DOX has a better inhibitory effect on SMMC-7721 cells than does a single target drug delivery system (FGP*DOX). The results of drug release analysis and cell inhibition studies showed that TFGP*DOX has a good sustained release function that can reduce the drug release rate in blood circulation over time and improve the local drug concentration in or near a targeted tumor. Therefore, the drug loading system (TFGP*DOX) has potential application value in the treatment of hepatocellular carcinoma.

Topics & Concepts

Drug deliveryDrugPharmacologyTransferrinTargeted drug deliveryDoxorubicinMedicineChemistryChemotherapyMaterials scienceBiochemistryNanotechnologySurgeryGraphene and Nanomaterials ApplicationsNanoparticle-Based Drug DeliveryGraphene research and applications
Preparation and anti-cancer activity of transferrin/folic acid double-targeted graphene oxide drug delivery system | Litcius